Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- PIXY +103.7%, OHRP +5.3%, RENN +3.9%, JBL +3.8%, COST +2.4%, ADBE +1.7%.
Other news:
- DCIX +43.7% (Morgan Stanley discloses 5.3% passive stake),
- EGLT +20.8% (receives tentative FDA approval for an expanded label for ARYMO ER (1.01)
- DDR +13.1% (higher after announcing plan to spin off portfolio of 50 assets; will host call today at 5pm ET),
- SIEB +11.2% (Continued strength after signing agreement with OPSTK yesterday)
- ACRS +9.2% (receives FDA approval for ESKATA for the treatment of raised seborrheic keratoses)
- ALNY +7.6% (Announced with SNY that the FDA has lifted the hold on clinical studies with fitusiran)
- HES +6% (WSJ reporting that activist Elliot is seeking to remove the CEO or push for sale),
- GLNG +5.1% (seeing strength after Karen Finerman pitched on CNBC),
- HST +2.5% (announces special dividend of $0.05/share),
- DISCA +2.3% (Director John Malone disclosed the purchase of more than 330K shares valued at approx $6.6 mln),
- PBR +1.4% (Exxon Mobil and Petrobras signed a memorandum of understanding regarding a strategic alliance to jointly identify and evaluate potential business opportunities),
- TWO +0.7% (modestly higher after declaring quarterly dividend of $0.47 per share of common stock; expects $0.47 per share amount to be sustainable into 2018), .
Analyst comments:
- CROX +4.2% (upgraded to Buy from Hold at Stifel)
- TEVA +4% (upgraded to Buy from Neutral at Goldman)
- FL +2.6% (upgraded to Buy from Hold at Canaccord Genuity)
- PRAH +0.8% (initiated with an Overweight at Mitsubishi UFJ)